Abstract：Objective To observe the influence of Shengxuening Tablets adjuvant chemotherapy on T lymphocyte subsets and interleukin-23 (IL-23) and interleukin-17 (IL-17) levels of postoperative patients with lung cancer. Methods Ninety-two cases of postoperative patients with lung cancer treated in Affiliated Hospital of Chengde Medical University from October 2015 to January 2017 were selected as the study objects, and they were divided into observation group and control group according to random number table method, with 46 cases in each group. The control group was given concurrent chemoradiotherapy, and the observation group was added with Shengxuening Tablets on the basis of the control group. After treatment, the clinical efficacy was evaluated, and the peripheral blood, immune function, levels of IL-23 and IL-17, and the incidence of adverse reactions were observed in the two groups. Results The total effective rate of the observation group (73.91%) was significantly higher than that of the control group (52.17%) (P ＜ 0.05). After treatment, the platelets, leukocytes, neutrophils in the two groups were significantly lower than those before treatment (P ＜ 0.05), and those in the observation group were significantly lower than those in the control group (P ＜ 0.05). There was no significant difference of hemoglobin before and after treatment (P ＞ 0.05). There were no significant differences of the levels of CD3+, CD4+ and CD8+ in the observation group before and after treatment (P ＞ 0.05), while the level of CD4+/CD8+ in the observation group after treatment was significantly lower than that before treatment (P ＜ 0.05). After treatment, the levels of CD3+, CD4+ and CD4+/CD8+ in the control group were significantly lower than those before treatment (P ＜ 0.05), the level of CD8+ was significantly higher than that before treatment (P ＜ 0.05). After treatment, the levels of CD3+, CD4+ and CD4+/CD8+ in the observation group were significantly higher than those in the control group (P ＜ 0.05), and the level of CD8+ was significantly lower than that in the control group (P ＜ 0.05). After treatment, the levels of IL-23 and IL-17 in the two groups were all significantly lower than those before treatment (P ＜ 0.05), which in the observation group were significantly lower than those in the control group (P ＜ 0.05). There was no serious liver and kidney dysfunction, and there was no significant differences in the incidence of radiation pneumonitis and radiation esophagitis between the two groups (P ＞ 0.05). The incidence of gastrointestinal reactions and myelosuppression in the observation group was significantly lower than that in the control group (P ＜ 0.05). Conclusion Shengxuening Tablets adjuvant chemotherapy can effectively improve peripheral blood and T lymphocyte subsets, reduce the levels of IL-23, IL-17 and the incidence of adverse reactions, which can improve clinical efficacy.
2018, Vol. 15 
京公网安备 11010502046598号